Carbamazepine inhibits ATP-sensitive potassium channel activity by disrupting channel response to MgADP

Channels

Volumn 8, Issue 4, 2014, Pages 376-382

  Zhou, Qing ^a   Chen, Pei Chun ^a,b   Devaraneni, Prasanna K ^a   Martin, Gregory M ^a   Olson, Erik M ^a   Shyng, Show Ling ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Gating; Pharmacological chaperones; Sulfonylurea receptor 1; Sulfonylureas

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DRUG RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL;

ANIMAL; METABOLISM;

ADENOSINE TRIPHOSPHATE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; KATP CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG;

EID: 84905829301     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.29117     Document Type: Article

References (31)

1. th, Gonzalez G, Kunjilwar K, Babenko A, Bryan J. Toward understanding the assembly and structure of KATP channels. Physiol Rev 1998; 78:227-45; PMID:9457174
2. Nichols CG. KATP channels as molecular sensors of cellular metabolism. Nature 2006; 440:470-6; PMID:16554807; http://dx.doi.org/10.1038/nature04711
3. Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 2005; 115:2047-58; PMID:16075046; http://dx.doi.org/10. 1172/JCI25495
4. Bienengraeber M, Olson TM, Selivanov VA, Kathmann EC, O'Cochlain F, Gao F, Karger AB, Ballew JD, Hodgson DM, Zingman LV, et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet 2004; 36:382-7; PMID:15034580; http://dx.doi.org/10.1038/ ng1329
5. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004; 350:1838-49; PMID:15115830; http://dx.doi.org/10.1056/NEJMoa032922
6. Harakalova M, van Harssel JJ, Terhal PA, van Lieshout S, Duran K, Renkens I, Amor DJ, Wilson LC, Kirk EP, Turner CL, et al. Dominant missense mutations in ABCC9 cause Cantú syndrome. Nat Genet 2012; 44:793-6; PMID:22610116; http://dx.doi.org/10.1038/ng.2324
7. Nichols CG, Singh GK, Grange DK. KATP channels and cardiovascular disease: suddenly a syndrome. Circ Res 2013; 112:1059-72; PMID:23538276; http://dx.doi.org/10.1161/CIRCRESAHA.112.300514
8. Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF, Bryan J. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268:426-9; PMID:7716548; http://dx.doi.org/10.1126/science.7716548
9. Aguilar-Bryan L, Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 1999; 20:101-35; PMID:10204114
10. Tucker SJ, Gribble FM, Zhao C, Trapp S, Ashcroft FM. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature 1997; 387:179-83; PMID:9144288; http://dx.doi.org/10.1038/ 387179a0
11. Zingman LV, Alekseev AE, Bienengraeber M, Hodgson D, Karger AB, Dzeja PP, Terzic A. Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance. Neuron 2001; 31:233-45; PMID:11502255; http://dx.doi.org/10.1016/S0896-6273(01)00356-7
12. Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M, Froguel P. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006; 355:456-66; PMID:16885549; http://dx.doi.org/10.1056/NEJMoa055068
13. Koster JC, Remedi MS, Dao C, Nichols CG. ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy. Diabetes 2005; 54:2645-54; PMID:16123353; http://dx.doi.org/10.2337/diabetes.54.9.2645
14. Zhou Q, Garin I, Castaño L, Argente J, Muñoz-Calvo MT, Perez de Nanclares G, Shyng SL. Neonatal diabetes caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels. J Clin Endocrinol Metab 2010; 95:E473-8; PMID:20810569; http://dx.doi.org/10.1210/jc.2010-1231
15. th, Gonzalez G, Aguilar-Bryan L, Permutt MA, Bryan J. Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 1996; 272:1785-7; PMID:8650576; http://dx.doi.org/10.1126/science.272.5269.1785
16. Shyng SL, Ferrigni T, Shepard JB, Nestorowicz A, Glaser B, Permutt MA, Nichols CG. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy. Diabetes 1998; 47:1145-51; PMID:9648840; http://dx.doi.org/10.2337/diabetes.47.7.1145
17. Martin GM, Chen PC, Devaraneni P, Shyng SL. Pharmacological rescue of trafficking-impaired ATP-sensitive potassium channels. Frontiers in physiology 2013; 4:386.
18. Gribble FM, Tucker SJ, Ashcroft FM. The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation. J Physiol 1997; 504:35-45; PMID:9350615; http://dx.doi.org/10.1111/j.1469-7793.1997.00035.x
19. Yan F, Lin CW, Weisiger E, Cartier EA, Taschenberger G, Shyng SL. Sulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptor. J Biol Chem 2004; 279:11096-105; PMID:14707124; http://dx.doi.org/10.1074/jbc.M312810200
20. Yan FF, Lin YW, MacMullen C, Ganguly A, Stanley CA, Shyng SL. Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue. Diabetes 2007; 56:2339-48; PMID:17575084; http://dx.doi.org/10.2337/db07-0150
21. Chen PC, Olson EM, Zhou Q, Kryukova Y, Sampson HM, Thomas DY, Shyng SL. Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism. J Biol Chem 2013; 288:20942-54; PMID:23744072; http://dx.doi.org/10.1074/jbc.M113. 470948
22. Trapp S, Tucker SJ, Ashcroft FM. Activation and inhibition of K-ATP currents by guanine nucleotides is mediated by different channel subunits. Proc Natl Acad Sci U S A 1997; 94:8872-7; PMID:9238070; http://dx.doi.org/10.1073/ pnas.94.16.8872
23. Ambrósio AF, Soares-Da-Silva P, Carvalho CM, Carvalho AP. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res 2002; 27:121-30; PMID:11926264; http://dx.doi.org/10.1023/A:1014814924965
24. Ambrósio AF, Silva AP, Malva JO, Soares-da-Silva P, Carvalho AP, Carvalho CM. Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists. Neuropharmacology 1999; 38:1349-59; PMID:10471089; http://dx.doi.org/10.1016/ S0028-3908(99)00058-1
25. Granger P, Biton B, Faure C, Vige X, Depoortere H, Graham D, Langer SZ, Scatton B, Avenet P. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Mol Pharmacol 1995; 47:1189-96; PMID:7603459
26. Bienengraeber M, Alekseev AE, Abraham MR, Carrasco AJ, Moreau C, Vivaudou M, Dzeja PP, Terzic A. ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex. FASEB J 2000; 14:1943-52; PMID:11023978; http://dx.doi.org/10.1096/fj.00-0027com
27. Ortiz D, Gossack L, Quast U, Bryan J. Reinterpreting the action of ATP analogs on K(ATP) channels. J Biol Chem 2013; 288:18894-902; PMID:23665564; http://dx.doi.org/10.1074/jbc.M113.476887
28. Ortiz D, Voyvodic P, Gossack L, Quast U, Bryan J. Two neonatal diabetes mutations on transmembrane helix 15 of SUR1 increase affinity for ATP and ADP at nucleotide binding domain 2. J Biol Chem 2012; 287:17985-95; PMID:22451668; http://dx.doi.org/10.1074/jbc.M112.349019
29. de Wet H, Proks P, Lafond M, Aittoniemi J, Sansom MS, Flanagan SE, Pearson ER, Hattersley AT, Ashcroft FM. A mutation (R826W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes. EMBO Rep 2008; 9:648-54; PMID:18497752; http://dx.doi.org/10.1038/ embor.2008.71
30. de Wet H, Rees MG, Shimomura K, Aittoniemi J, Patch AM, Flanagan SE, Ellard S, Hattersley AT, Sansom MS, Ashcroft FM. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes. Proc Natl Acad Sci U S A 2007; 104:18988-92; PMID:18025464; http://dx.doi.org/10.1073/pnas.0707428104
31. Mlynarski W, Tarasov AI, Gach A, Girard CA, Pietrzak I, Zubcevic L, Kusmierek J, Klupa T, Malecki MT, Ashcroft FM. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nat Clin Pract Neurol 2007; 3:640-5; PMID:17982434; http://dx.doi.org/10.1038/ ncpneuro0640